This information is intended only for healthcare professionals resident in the Great Britain

Prescribing Information (PI) for Cresemba® (isavuconazole) and VFEND (voriconazole) Great Britain (GB) and Northern Ireland (NI)

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Cresemba (isavuconazole) 200mg powder for concentrate for solution for infusion - PI for GB
  • Cresemba (isavuconazole) 100mg Hard Capsules - PI for GB

Northern Ireland

  • Cresemba (isavuconazole) 200mg powder for concentrate for solution for infusion and 100mg Hard Capsules - PI for NI

Great Britain

  • Vfend (voriconazole) 200mg powder for solution for infusion - PI for GB
  • Vfend (voriconazole) 50mg film-coated tablets - PI for GB
  • Vfend (voriconazole) 200mg film-coated tablets - PI for GB
  • Vfend (voriconazole) 40mg powder for oral suspension - PI for GB

Northern Ireland

  • Vfend (voriconazole) 50mg and 200mg film-coated tablets, 40mg powder for oral suspension - PI for NI

Cresemba (isavuconazole) 200mg powder for concentrate for solution for infusion - PI for GB

Cresemba (isavuconazole) 100mg Hard Capsules - PI for GB

Cresemba (isavuconazole) 200mg powder for concentrate for solution for infusion and 100mg Hard Capsules - PI for NI

Vfend (voriconazole) 200mg powder for solution for infusion - PI for GB

Vfend (voriconazole) 50mg film-coated tablets - PI for GB

Vfend (voriconazole) 200mg film-coated tablets - PI for GB

Vfend (voriconazole) 40mg powder for oral suspension - PI for GB

Vfend (voriconazole) 50mg and 200mg film-coated tablets, 40mg powder for oral suspension - PI for NI

PP-CRB-GBR-1569. May 2022